Thiolated chitosan masked polymeric microspheres with incorporated mesocellular silica foam (MCF) for intranasal delivery of paliperidone

Polymers

Volumn 9, Issue 11, 2017, Pages

  Nanaki, Stavroula ^a   Tseklima, Maria ^a   Christodoulou, Evi ^a   Triantafyllidis, Konstantinos ^a   Kostoglou, Margaritis ^a   Bikiaris, Dimitrios N ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Drug encapsulation; Mesoporous cellular foam; Microspheres; Paliperidone; PLA; PLGA; Thiolated chitosan

Indexed keywords

CHITIN; CHITOSAN; DISSOLUTION; ENCAPSULATION; POLYMERS; SILICA;

CELLULAR FOAMS; DRUG ENCAPSULATION; PALIPERIDONE; PLGA; THIOLATED CHITOSAN;

MICROSPHERES;

EID: 85034425514     PISSN: None     EISSN: 20734360     Source Type: Journal    
DOI: 10.3390/polym9110617     Document Type: Article

References (51)

1. Kresge, C.T.; Leonowilz, M.E.; Roth, W.J.; Vartuli, J.C.; Beck, J.S. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 1992, 359, 710-712
2. Munoz, B.; Ramila, A.; Perez-Pariente, J.; Diaz, I.; Vallet-Regi, M. MCM-41 Organic modification as drug delivery rate regulator. Chem. Mater. 2003, 15, 500-503
3. Han, Y.J.; Stucky, G.D.; Butler, A. Mesoporous silicate sequestration and release of proteins. J. Am. Chem. Soc. 1999, 121, 9897-9898
4. Arruebo, M.; Galan, M.; Navascues, N.; Tellez, C.; Marquina, C.; Ibarra, M.R.; Santamaria, J. Development of magnetic nanostructured silica-based materials as potential vectors for drug-delivery applications. Chem. Mater. 2006, 18, 1911-1919
5. Arruebo, M.; Fernandez-Pacheco, R.; Irusta, S.; Arbiol, J.; Ibarra, M.R.; Santamaria, J. Sustained release of doxorubicin from zeolite-magnetite nanocomposites prepared by mechanical activation. Nanotechnology 2006, 17, 4057-4064
6. Radu, D.R.; Lai, C.Y.; Jeftinija, K.; Rowe, E.W.; Jeftinija, S.; Lin, V.S.Y. A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. J. Am. Chem. Soc. 2004, 126, 13216-13217
7. Lin, Y.S.; Tsai, C.P.; Huang, H.Y.; Kuo, C.T.; Hung, Y.; Huang, D.M.; Chen, Y.C.; Mou, C.Y. Well-ordered mesoporous silica nanoparticles as cell markers. Chem. Mater. 2005, 17, 4570-4573
8. Lai, C.Y.; Trewyn, B.G.; Jeftinija, D.M.; Jeftinija, K.; Xu, S.; Jeftinija, S.; Lin, V.S.Y. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J. Am. Chem. Soc. 2003, 125, 4451-4459
9. Zhang, Y.; Zhang, J.; Jiang, T.;Wang, S. Inclusion of the poorly water-soluble drug simvastatin in mesocellular foam nanoparticles: Drug loading and release properties. Int. J. Pharm. 2011, 410, 118-124
10. Zhang, Y.; Jiang, T.; Zhang, Q.; Wang, S. Inclusion of telmisartan in mesocellular foam nanoparticles: Drug loading and release property. Eur. J. Pharm. Biopharm. 2010, 76, 17-23
11. Lee, C.H.; Lo, L.W.; Mou, C.Y.; Yang, C.S. Synthesis and characterization of positive-charge functionalized mesoporous silica nanoparticles for oral drug delivery of an anti-inflammatory drug. Adv. Funct. Mater. 2008, 18, 3283-3292
12. Slowing, I.I.; Vivero-Escoto, J.L.; Wu, C.W.; Lin, V.S.Y. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. 2008, 60, 1278-1288
13. Zhang, Y.; Zhi, Z.; Jiang, T.; Zhang, J.; Wang, Z.; Wang, S. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan. J. Control. Release 2010, 145, 257-263
14. Lu, J.; Liong, M.; Zink, J.I.; Tamanoi, F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 2007, 3, 1341-1346
15. Rosenholm, J.M.; Sahlgren, C.; Linden, M. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles-Opportunities & challenges. Nanoscale 2010, 2, 1870-1883
16. Meltzer, H.; Kramer, M.; Gassmann-Mayer, C.; Lim, P.; Bobo, W.; Eerdekens, M. Efficacy and tolerability of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: Pooled data from three 6-week placebo-controlled studies. J. Clin. Psychiatry 2006, 69, 817-829
17. Darville, N.; van Heerden, M.; Vynckier, A.; De Meulder, M.; Sterkens, P.; Annaert, P.; Van den Mooter, G. Intramuscular administration of paliperidone palmitate extended-release injectable microsuspension induces a subclinical inflammatory reaction modulating the pharmacokinetics in rats. J. Pharm. Sci. 2014, 103, 2072-2087
18. Nanaki, S.; Tseklima, M.; Terzopoulou, Z.; Nerantzaki, M.; Giliopoulos, D.J.; Triantafyllidis, K.; Kostoglou, M.; Bikiaris, D.N. Use of mesoporous cellular foam (MCF) in preparation of polymeric microspheres for long acting injectable release formulations of paliperidone antipsychotic drug. Eur. J. Pharm. Biopharm. 2017, 117, 77-90
19. Gao, X.; Tao,W.; Lu,W.; Zhang, Q.; Zhang, Y.; Jiang, X.; Fu, S. Lectin-conjugated PEG-PLA nanoparticles: Preparation and brain delivery after intranasal administration. Biomaterials 2006, 27, 3482-3490
20. Vila, A.; Sanchez, A.; Evora, C.; Soriano, I.; McCallion, O.; Alonso, M.J. PLA-PEG particles as nasal protein carriers: The influence of the particle size. Int. J. Pharm. 2005, 292, 43-52
21. Csaba, N.; Sánchez, A.; Alonso, M.J. PLGA: Poloxamer and PLGA: Poloxamine blend nanostructures as carriers for nasal gene delivery. J. Control. Release 2006, 113, 164-172
22. Darville, N.; Heerden, M.; Mariën, D.; DeMeulder, M.; Rossenu, S.; Vermeulen, A.; Vynckier, A.; De Jonghe, S.; Sterkens, P.; Annaert, P.; et al. The effect of macrophage and angiogenesis inhibition on the drug release and absorption from an intramuscular sustained-release paliperidone palmitate suspension. J. Control. Release 2016, 230, 95-108
23. Koukaras, E.N.; Papadimitriou, S.A.; Bikiaris, D.N.; Froudakis, G.E. Properties and energetics for design and characterization of chitosan nanoparticles used for drug encapsulation. RSC Adv. 2014, 4, 12653-12661
24. Van der Lubben, I.M.; Verhoef, J.C.; Borchard, G.; Junginger, H.E. Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur. J. Pharm. Sci. 2001, 14, 201-207
25. Wong, T.W. Chitosan and its use in design of insulin delivery system. Recent Pat. Drug Deliv. Formul. 2009, 3, 8-25
26. Henriksen, I.; Green, K.L.; Smart, J.D.; Smistad, G.; Karlsen, J. Bioadhesion of hydrated chitosan: An in vitro and in vivo study. Int. J. Pharm. 1996, 145, 231-240
27. Schipper, N.G.; Olsson, S.; Hoogstraate, J.A.; deBoer, A.G.; Varum, K.M.; Artursson, P. Chitosans as absorption enhancers for poorly absorbable drugs 2: Mechanism of absorption enhancement. Pharm. Res. 1997, 14, 923-929
28. Lehr, C.M.; Bouwstra, J.A.; Schacht, E.H.; Junginger, H.E. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 1992, 78, 43-48
29. Artursson, P.; Lindmark, T.; Davis, S.S.; Illum, L. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res. 1994, 11, 1358-1361
30. Zahir-Jouzdani, F.; Mahbod, M.; Soleimani, M.; Vakhshiteh, F.; Arefian, E.; Shahosseini, S.; Dinarvand, R.; Atyabi, F. Chitosan and thiolated chitosan: Novel therapeutic approach for preventing corneal haze after chemical injuries. Carbohydr. Polym. 2018, 17, 42-49
31. Anitha, A.; Deepa, N.; Chennazhi, K.P.; Nair, S.V.; Tamura, H.; Jayakumar, R. Development of mucoadhesive thiolated chitosan nanoparticles for biomedical applications. Carbohydr. Polym. 2011, 83, 66-73
32. Sreenivas, S.A.; Pai, K.V. Thiolated Chitosans: Novel polymers for mucoadhesive drug delivery-A Review. Trop. J. Pharm. Res. 2008, 7, 1077-1088
33. Mahmood, A.; Lanthaler, M.; Laffleur, F.; Huck, C.W.; Bernkop-Schnürch, A. Thiolated chitosan micelles: Highly mucoadhesive drug carriers. Carbohydr. Polym. 2017, 167, 250-258
34. Duggan, S.; Cummins, W.; O'Donovan, O.; Hughes, H.; Owens, E. Thiolated polymers as mucoadhesive drug delivery systems. Eur. J. Pharm. Sci. 2017, 100, 64-78
35. Menzel, C.; Jelkmann, M.; Laffleur, F.; Bernkop-Schnürch, A. Nasal drug delivery: Design of a novel mucoadhesive and in situ gelling polymer. Int. J. Pharm. 2017, 517, 196-202
36. Schmidt-Winkel, P.; Lukens,W.W.; Zhao, J.D.; Yang, P.; Chmelka, B.F.; Stucky, G.D. Mesocellular siliceous foams with uniformly, sized cells and windows. J. Am. Chem. Soc. 1999, 121, 254-255
37. Zhu, X.; Su, M.; Tang, S.;Wang, L.; Liang, X.; Meng, F.; Hong, Y.; Xu, Z. Synthesis of thiolated chitosan and preparation nanoparticles with sodium alginate for ocular drug delivery. Mol. Vis. 2012, 18, 1973-1982
38. Filippousi, M.; Siafaka, P.I.; Amanatiadou, E.P.; Nanaki, S.G.; Nerantzaki, M.; Bikiaris, D.N.; Vizirianakis, I.S.; Van Tendeloo, G. Modified chitosan coated mesoporous strontium hydroxyapatite nanorods as drug carriers. J. Mater. Chem. B 2015, 3, 5991-6000
39. Jiang, L.; Li, X.; Liu, L.; Zhang, Q. Thiolated chitosan-modified PLA-PCL-TPGS nanoparticles for oral chemotherapy of lung cancer. Nanoscale Res. Lett. 2013, 8, 66
40. Azeem, A.; Iqbal, Z.; Ahmad, F.; Khar, K.; Talegaonkar, S. Development and validation of a stability-indicating method for determination of ropinirole in the bulk drug and in pharmaceutical dosage forms. Acta Chromatogr. 2008, 20, 95
41. Li, J.; Liu, D.; Tan, G.; Zhao, Z.; Yang, X.; Pan, W. A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin. Carbohydr. Polym. 2016, 146, 435-444
42. Yin, L.; Ding, J.; He, C.; Cui, L.; Tang, C.; Yin, C. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials 2009, 30, 5691-5700
43. Chrissafis, K.; Paraskevopoulos, K.M.; Papageorgiou, G.Z.; Bikiaris, D.N. Thermal and dynamic mechanical behaviour of bionanocomposites: Fumed silica nanoparticles dispersed in poly(vinyl pyrrolidone), chitosan and poly(vinyl alcohol). J. Appl. Polym. Sci. 2008, 110, 1739-1749
44. Bikiaris, D.N. Solid dispersions, Part I: Recent evolutions & future opportunities in manufacturing methods for dissolution rate enhancement of poorly water soluble drugs. Expert Opin. Drug Deliv. 2011, 8, 1501-1519
45. Bikiaris, D.N. Solid dispersions, Part II: New strategies in manufacturing methods for dissolution rate enhancement of poorly water soluble drugs. Expert Opin. Drug Deliv. 2011, 8, 1663-1689
46. Papageorgiou, G.Z.; Achilias, D.S.; Nanaki, S.; Beslikas, T.; Bikiaris, D. PLA nanocomposites: Effect of filler type on non-isothermal crystallization. Thermochim. Acta 2010, 511, 129-139
47. Kyzas, G.Z.; Kostoglou, M. Swelling-adsorption interactions during mercury and nickel ions removal by chitosan derivatives. Sep. Purif. Technol. 2015, 149, 92-102
48. Kyzas, G.Z.; Lazaridis, N.K.; Kostoglou, M. Modelling the effect of pre-swelling on adsorption dynamics of dyes by chitosan derivatives. Chem. Eng. Sci. 2012, 81, 220-230
49. Tien, C. Adsorption Calculations and Modeling; Butterworth-Heinemann: Boston, MA, USA, 1994
50. Crank, J. The Mathematics of Diffusion; Oxford University Press: Oxford, UK, 1975
51. Georgiadis, M.C.; Kostoglou, M. On the optimization of drug release from multi-laminate polymer matrix devices. J. Control. Release 2002, 77, 273-285